BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30111774)

  • 21. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.
    O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE
    Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
    Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
    FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.
    Danussi C; Coslovi A; Campa C; Mucignat MT; Spessotto P; Uggeri F; Paoletti S; Colombatti A
    Glycobiology; 2009 Oct; 19(10):1056-67. PubMed ID: 19528665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Sialyl-Tn in Cancer.
    Munkley J
    Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
    Seko A; Ohkura T; Ideo H; Yamashita K
    Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
    Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
    Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
    Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
    Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
    Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
    PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.
    Cao Y; Karsten U
    Histochem Cell Biol; 2001 Apr; 115(4):349-56. PubMed ID: 11405064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
    Fujita R; Hamano H; Kameda Y; Arai R; Shimizu T; Ota M; Sato D; Kobayashi H; Iwasaki N; Takahata M
    Clin Exp Metastasis; 2019 Dec; 36(6):539-549. PubMed ID: 31595388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
    Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
    PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis.
    Kristiansen G; Machado E; Bretz N; Rupp C; Winzer KJ; König AK; Moldenhauer G; Marmé F; Costa J; Altevogt P
    Lab Invest; 2010 Jul; 90(7):1102-16. PubMed ID: 20351695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of a tumor-specific monoclonal antibody ACT19 recognizing an epitope distinctive from sialosyl-Tn on the TAG72 antigen.
    Xiang J; Moyana T; Chen Z; Han W; Ping T; Li E
    Tumori; 1993 Feb; 79(1):58-65. PubMed ID: 7684540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
    Gidwani K; Nadeem N; Huhtinen K; Kekki H; Heinosalo T; Hynninen J; Perheentupa A; Poutanen M; Carpen O; Pettersson K; Lamminmäki U
    J Appl Lab Med; 2019 Nov; 4(3):299-310. PubMed ID: 31659068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
    Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
    Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
    Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
    Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
    Lima L; Neves M; Oliveira MI; Dieguez L; Freitas R; Azevedo R; Gaiteiro C; Soares J; Ferreira D; Peixoto A; Fernandes E; Montezuma D; Tavares A; Ribeiro R; Castro A; Oliveira M; Fraga A; Reis CA; Santos LL; Ferreira JA
    Urol Oncol; 2017 Dec; 35(12):675.e1-675.e8. PubMed ID: 28911924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.
    MacLean GD; Reddish MA; Koganty RR; Longenecker BM
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):59-68. PubMed ID: 8859725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.